The largest database of trusted experimental protocols

Diltiazem

Diltiazem is a calcium channel blocker medication used to treat hypertension, angina pectoris, and certain heart rhythm disorders.
It works by relaxing blood vessels and reducing the workload on the heart.
Diltiazem is commonly prescribed to manage cardiovascular conditions, but its optimal use requires careful consideration of dosage, interactions, and patient factors.
This MeSH term provides a concise overview of Diltiazem's pharmacological properties and clinical applications.

Most cited protocols related to «Diltiazem»

The present study was based on the Taiwan Primary Aldosteronism Investigation (TAIPAI) database and tissue bank16 (link)17 (link)18 (link). The database was constructed from June 2008 to March 2011 for quality assurance at 2 medical centers and their 3 affiliated hospitals and two local hospitals in different cities in Taiwan19 (link). Before confirmatory tests, all antihypertensive medications were discontinued for at least 21 days. Diltiazem and/or doxazosin were administered to control markedly high blood pressure when required1 (link). Patients with an abnormal aldosterone-renin ratio (ARR) were confirmed with PA by saline infusion tests, and subsequently underwent imaging studies for subtype identification (figures S1 and S2).
PA confirmation and subtype studies were established in hypertensive patients according to the standard protocol of TAIPAI59 , including adrenal venous sampling and NP-59 scintigraphy with SPECT-CT imaging16 (link)17 (link)18 (link)20 (link) (see the supplementary file). Patients who were diagnosed with family type I (FH-I)/GRA were excluded via long-range polymerase chain reaction, as described previously21 (link).
Full text: Click here
Publication 2015
Aldosterone Antihypertensive Agents Conn Syndrome Diltiazem Doxazosin High Blood Pressures NP-59 Patients Polymerase Chain Reaction Radionuclide Imaging Renin Saline Solution Single Photon Emission Computed Tomography Computed Tomography Tissues Tomography, Emission-Computed, Single-Photon Veins X-Ray Computed Tomography
The present study was based on the Taiwan Primary Aldosteronism Investigation (TAIPAI) database. From June 2006 to March 2008, the random urine and 24-h urine samples of the referred patients were routinely analyzed. A total of 222 hypertensive patients were referred to our hypertension clinic for the confirmation of PA after an initial evaluation. The database was constructed for quality assurance in 1 medical center (National Taiwan University Hospital, Taipei, Taiwan) and its 3 affiliated hospitals in different cities (National Taiwan University Hospital Yun-Lin branch, Yun-Lin, southern Taiwan; Tzi-Chi Hospital, Taipei; and Tao-Yuan General Hospital, Tao-Yuan, central Taiwan). All patients hospitalized with the intention to confirm PA diagnosis and who received salt loading test were recruited. Patients were excluded because of loss to follow-up (n = 13), incomplete urinary collection (n = 18), chronic kidney disease with a decreased estimated glomerular filtration rate ([GFR] <60 mL/[min·1.73 m2]; n = 11), heart failure, New York Heart Association (NYHA) class II or higher (n = 5), hyperthyroidism (n = 2), and malignancy with metastasis (n = 6) (Fig. 1). All antihypertensive medications were discontinued for at least 21 days before the study. Diltiazem and/or doxazosin were administered for control of marked high blood pressure when required [1] (link). Medications that might interfere with the renin-aldosterone axis, including steroids, sex hormones, licorice, or non-steroidal anti-inflammatory drugs, were also withheld.
Full text: Click here
Publication 2013
Aldosterone Anti-Inflammatory Agents, Non-Steroidal Antihypertensive Agents Chronic Kidney Diseases Congestive Heart Failure Conn Syndrome Diagnosis Diltiazem Doxazosin Epistropheus Glycyrrhiza Gonadal Steroid Hormones Heart High Blood Pressures Hyperthyroidism Neoplasm Metastasis Patients Pharmaceutical Preparations Renin Sodium Chloride, Dietary Steroids Urine Urine Specimen Collection
Daphnids were maintained in glass beakers in OECD media (final concentrations 0.29 g CaCl2.2H2O/L, 0.123 g MgSO4.7H2O/L, 0.065 g NaHCO3/L, 0.0058 g KCl/L, 2 μg Na2SeO3/L, pH 7.7) at a density of 80 adults per 4 L of media and under a 16h:8h of light:dark photoperiod at 20 °C [7 (link)]. For experiments, neonates (<24 h) were collected from the third brood of their mothers and cultured until four days old, and then used for experiments. Typically, in experiments with daphnids, acute toxicity is performed with neonates (<24 h); however, in several cases this has proven to be not reproducible, mainly because of the time window of neonate selection which extends to up to 24 h, thus resulting in a less homogenous population for experiments affecting toxicity [8 (link)]. Furthermore, as acute exposures are performed in the absence of food, the animals experience an additional stress of starvation which we avoided by allowing them to grow over a period of four days prior to exposure to the chemicals. Based on the selection of 24 h exposure periods, the chemicals were only added once following the general outlined procedure of the OECD guidelines [9 ]. The chemicals used in this study were aluminium (CAS 16828-11-8), lithium (CAS 7447-41-8), acetylsalicylic acid (CAS 50-78-2), diltiazem (CAS 33286-22-5), metformin (CAS 115-70-4), propranolol (CAS 318-98-9), glyphosate (CAS 1071-83-6) and nicotine (CAS 54-11-5). All chemicals were of highest purity >99.9%.
For exposures, 15 four-day-old animals were exposed to each chemical separately in a final volume of 100 mL OECD media with four replicates per concentration tested. Toxicity curves were plotted for 24 h exposures and EC values were calculated. A mixture was constructed for all chemicals and further assessed for its toxicity (Figure 1). All plots were calculated using the Four parameter logistic (4PL) model, following the equation Span = Top − Bottom and Y = Bottom + (Top-Bottom)/(1 + 10^((LogIC50-X)*HillSlope)), using the GraphPad software. The parameters top and bottom were commonly fixed to 100 and 0, accordingly.
Full text: Click here
Publication 2022
Adult Aluminum Animals Aspirin Bicarbonate, Sodium Diltiazem Food glyphosate Homozygote Infant, Newborn Light Lithium Metformin Mothers Nicotine Propranolol Sulfate, Magnesium
Light exposure elicits an increase in OR thickness as measured by OCT in mice and humans; the procedure has been previously published.22 (link)–24 (link, link),26 (link) Briefly, after anesthetizing mice with ketamine (100 mg/kg) and xylazine (6 mg/kg), retina OCT images were captured with Envisu UHR2200 (Bioptigen, Durham, NC, USA), with OCT beam bandwidth of 160 nm, and theoretic axial resolution of 1.6 μm in tissue. The mouse eye was positioned with the optic nerve head (ONH) in the center of the OCT scan. Full-field (50° fixed field view, corresponding to 1.4 mm × 1.4 mm for a typical mouse eye) volume scans (at 1000 A-scan × 100 B-scan × 5) and a vertical B-scan (averaged 40 times) were collected. Mice used in this study were of similar age, so between-mice eye size differences were small. Vertical B-scan images were studied from our previous results showing that d-cis-diltiazem produces oxidative stress in superior and inferior retina,9 (link) and OR thickness was measured at location ∼450 μm superior (“12-o'clock” position) and ∼450 μm inferior (“6-o'clock” position) to the center of the ONH, by using vendor-provided Reader program (Bioptigen) and an in-house MATLAB program. OR length was measured from external limiting membrane (ELM) to the RPE-choroid boundary.
Publication 2019
Choroid Diltiazem Homo sapiens Ketamine Light Mice, House Optic Disk Oxidative Stress Radionuclide Imaging Retina Tissue, Membrane Tissues Xylazine
Before subjecting the segments to different experimental conditions to obtain the vasoreactive measurements described below, the aortic segments were stretched and stabilized to one of the following preloads of 10, 16, 20, 28, 30, 40, 50, or 65 mN in Krebs Ringer solution at 37°C. Aortic segments of the same mouse were stretched to different preloads, and measurements were performed in parallel. Randomization of the segments was employed to exclude non-specific effects of the changes in aortic physiology between the proximal and distal segments of the thoracic aorta.
K+ concentration-contraction curves (KCC) were measured at different preloads by gradually increasing external K+ from 5.9 to 10, 15, 20, 25, 30, 35, 40, and 50 mM by isosmotic replacement of Na+ by K+ in Krebs Ringer solution. Concentration-contraction curves for α1 adrenoceptor stimulation of the aortic segments with phenylephrine (PECC) were cumulatively determined for concentrations of 3 × 10−9 to 3 × 10−6 M. Both KCC and PECC were fitted with sigmoidal concentration-response equations with variable slope (GraphPad Prism), which revealed maximal responses (Emax) and (the logarithm of) the concentration resulting in 50% of the maximal contraction (logEC50 for PE and EC50 for K+).
Phasic contractions by PE were measured by adding 1 μM PE to the segments incubated for 3 min in Krebs Ringer solution without extracellular Ca2+ and with 1 mM EGTA. These contractions are mediated by the IP3-dependent release of contractile Ca2+ from the SR (Fransen et al., 2015 (link)). After the phasic contraction, extracellular Ca2+ (3.5 mM) was added to measure the tonic contraction induced by Ca2+ influx in the PE-sensitized segment. Next, 35 μM diltiazem was added, to block the Ca2+ influx via voltage-gated Ca2+ channels. In this way, the contribution of VGCC and NSCC to the tonic contraction can be ascertained (Fransen et al., 2015 (link)). In some experiments, segments were incubated for 5 min with levcromakalim (1 μM), a KATP channel agonist, to repolarize aortic segments to the K+ equilibrium potential.
To assess the basal release of NO, contractions by elevated K+ or PE were measured in separate segments of the same mouse in the absence and presence of 300 μM L-NAME to inhibit eNOS. We have previously shown that this is the most sensitive way to measure basal NO release (van Langen et al., 2012 (link); Leloup et al., 2015b (link)). Relaxation of 1 μM PE-precontracted segments by endogenous and exogenous NO release was measured by constructing concentration-relaxation curves for acetylcholine (ACh, 3 × 10−9 to 3 × 10−6 M) and diethylamine NONOate (DEANO, 3 × 10−10 to 3 × 10−6 M), fitting the curves with sigmoidal concentration-response equations with variable slope (GraphPad Prism) to obtain Emax- and logEC50-values.
Full text: Click here
Publication 2017
1,1-diethyl-2-hydroxy-2-nitrosohydrazine Aorta Cardiac Arrest Diltiazem Egtazic Acid KATP Channels Krebs-Ringer solution Levcromakalim Mus Muscle Contraction NG-Nitroarginine Methyl Ester NOS3 protein, human Phenylephrine physiology prisma Receptors, Adrenergic, alpha-1 Thoracic Aorta

Most recents protocols related to «Diltiazem»

The collection time of the plasma sample included data from before administration of bepridil to up to 6 h after administration. To assess risk factors for achieving plasma bepridil concentrations ≥800 ng/mL at steady state, the eligible patients were divided into two groups based on their bepridil concentrations: ≥800 ng/mL and < 800 ng/mL.
The C/D ratio was calculated using the following equation:
C/D ratio of bepridil = plasma concentration of bepridil (ng/mL) / dose of bepridil (mg/day/kg body weight).
In this study, we defined the polypharmacy group as those who use six or more drugs, whereas the non-polypharmacy group was those who took fewer than six drugs. The relationship between plasma bepridil concentrations ≥800 ng/mL and baseline characteristics, including sex, age, height, body weight, body mass index, serum creatinine, creatinine clearance (Ccr), number of concomitant drugs used, typical inducers of CYPs (phenytoin, carbamazepine, phenobarbital, and rifampicin) [15 (link)], typical inhibitors of CYPs (erythromycin, clarithromycin, protease inhibitors, and azole antifungals) [15 (link)], aprindine, a competitive inhibitor of CYP2D6 [12 (link)], typical inhibitor of P-gp (amiodarone, diltiazem, nicardipine, nifedipine, propranolol, quinidine, cyclosporin, and tacrolimus) [16 (link)–18 (link)], and left ventricular ejection fraction (LVEF), were examined. LVEF was measured using echocardiographic equipment provided at each hospital. Ccr was estimated using the Cockcroft–Gault formula [19 (link)].
The patient’s medical history and duration of bepridil treatment were collected from medical records.
Full text: Click here
Publication 2023
Amiodarone Antifungal Agents Aprindine Azoles Bepridil Body Weight Carbamazepine Clarithromycin Creatinine Cyclosporine Cytochrome P-450 CYP2D6 Inhibitors Cytochrome P450 Diltiazem Echocardiography Erythromycin Index, Body Mass inhibitors Nicardipine Nifedipine Patients Pharmaceutical Preparations Phenobarbital Phenytoin Plasma Polypharmacy Propranolol Protease Inhibitors Quinidine Rifampin Serum Specimen Collection Tacrolimus Ventricular Ejection Fraction

Rubia cordifolia root material was purchased from the Wandong Bridge Chinese herbal medicine market in Nanming District, Guiyang City, Guizhou Province, and was positively identified by Associate Professor Long Qingde of Guizhou University of Traditional Chinese Medicine. The root material was boiled twice, and the decoctions from the two boilings were combined. The combined decoctions were filtered and concentrated to 1 g/mL, which is equivalent to raw material, and stored at 4°C for later use. This experiment has been approved by the Ethics Committee of Qionghai People's Hospital (Project No.: QH-20201120-0012).
Thirty-two healthy adult SD rats were randomly divided into the sham group (sham), the model group (model), the madder group (madder), and the diltiazem group (Dil). Seven days before surgery, rats in the model group and the sham group were injected with 1 mL normal saline every day, rats in the madder group were injected with madder extract (0.5 mg/kg) every day, and rats in the Dil group were injected with diltiazem (0.2 mg/kg) every day. I/R modeling was performed in the model group, the madder group, and the Dil group.
For the performance of the myocardial ischemia-reperfusion model [10 (link)], rats were anesthetized with pentobarbital sodium and immobilized on the operating table. Endotracheal intubation was performed on the rats, and a positive pressure ventilator was implanted to assist respiration. Left 3–4 rib space thoracotomy was done to break the pericardium to expose the heart. The left anterior descending coronary artery was ligated using a surgical lead. After ligation of the anterior descending branch for 30 min, the ligation line was relaxed, and reperfusion was performed for 1 h. The sham operation group was not subjected to ligation of the anterior descending branch, but the other steps were the same. Arterial flow and myocardial systolic rate were measured after operation.
Full text: Click here
Publication 2023
Adult Arteries Artery, Coronary Cell Respiration Chinese Diltiazem Ethics Committees, Clinical Heart Intubation, Intratracheal Ischemia Ligation Medicinal Herbs Myocardial Ischemia Myocardial Reperfusion Myocardium Normal Saline Operating Tables Pentobarbital Sodium Pericardium Plant Roots Pressure Rattus norvegicus Reperfusion Rubia cordifolia Systole Thoracotomy
Ca2+ levels in the capacitated spermatozoa were detected according to the previous study [18 (link)]. Briefly, the capacitated spermatozoa were incubated with 5 μM Fluo 3-AM (Dojindo Laboratories, Kumamoto, Japan) and 0.06% pluronic F-127 for 30 min at 39 °C in the dark. The capacitated spermatozoa (3–5 × 105 cells/mL) were placed on glass coverslips treated with polylysine at 0.01% in the recording chamber for 5 min, and then the external solution was infused to wash the supernatant. Imaging analysis of Ca2+ response in motile spermatozoa was monitored using a LSM 800 confocal microscope (Zeiss, Oberkochen, Germany). We used a sample frequency of 1 Hz, and recorded Ca2+ fluorescence intensity for 3–4 min after different treatments. All Ca2+ imaging experiments were carried out at 39 °C. Cells with uneven dye loading were excluded from the analysis. NPPC was used at 1 nM, and the inhibitor l-cis-Diltiazem was used at 50 μM with a pre-incubation of 15 sec. NPPC and the inhibitor were dropped into the recording chamber using pipette tips and the recordings were conducted in the continuous presence of stimuli. Ca2+-free experiments were conducted using Ca2+-free modified Tris-buffered medium (mTBM) without BSA, obtained by omitting Ca2+ and adding 1 mM EGTA. NNC 055-0396, 8-Br-cGMP, BAPTA/AM, and TMB-8 were used with 2 μM, 1 mM, 5 μM, and 10 μM, respectively. The highest level of Ca2+ fluorescence intensity in at least 50 spermatozoa was used for the presentation of Ca2+ level of spermatozoa in different treatment. Each experiment was repeated three times.
Full text: Click here
Publication 2023
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid 4-nitrophenylphosphorylcholine 8-bromocyclic GMP Cells Diltiazem Egtazic Acid Fluo-3 Fluorescence Microscopy, Confocal Pluronic F-127 Polylysine Sperm TMB-8
Assay of sperm binding to and release from oviduct isthmic cell aggregates was conducted according to the previous report [9 (link)]. Briefly, the spherical oviduct isthmic cell aggregates were washed twice in fresh dmTALP medium. Then, 2 µL spermatozoa at a final concentration of 5 × 105 cells/mL were added into a 50 µL droplet containing 10 oviduct isthmic cell aggregates. Spermatozoa and the oviduct isthmic cell aggregates were incubated at 39 °C for 15 min for sperm binding to form the complexes. Then, the complexes were incubated without or with 1 nM NPPC for 30 min at 39 °C. In some experiments, the complexes were pre-incubated with l-cis-Diltiazem (50 µM), NNC 055-0396 (2 μM), or BAPTA/AM (5 μM) for 5 min at 39 °C, and then incubated without or with NPPC. At the end of incubation, the free and loosely attached spermatozoa were removed from the oviduct isthmic cell aggregates by washing with dmTALP medium. The aggregates were fixed with 4% paraformaldehyde for 10 min and then transferred to a 3 µL droplet in the microscope slide. Images were captured using Axio Vert. A1 microscope (Zeiss, Oberkochen, Germany). The number of spermatozoa bound to the periphery of each aggregate was enumerated, and the circumference of the aggregate was calculated using Labscope V 3.2 software (Zeiss, Oberkochen, Germany). The number of spermatozoa bound per millimeter of circumference was calculated for each aggregate, and the average number of spermatozoa from 10 aggregates was used for statistical analysis. All the cultures were incubated at 39 °C under 5% CO2.
Full text: Click here
Publication 2023
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid 4-nitrophenylphosphorylcholine Biological Assay Cells Diltiazem Fallopian Tubes Microscopy paraform Sperm Verteporfin
The capacitated spermatozoa were incubated in dmTALP medium, supplemented with different concentrations of NPPC (0.01–10 nM), NNC 055-0396 (CatSper channel inhibitor, 2 μM), 8-Br-cGMP (1 mM), and/or l-cis-Diltiazem (CNG channels inhibitor, 50 μM) for 30 min. The sperm motion was detected using a CASA system (Version 12 CEROS, Hamilton Thorne Research, Beverly, MA, USA). The parameters included straight-line velocity (VSL), amplitude of lateral head displacement (ALH), average path velocity (VAP), curvilinear velocity (VCL), beat cross frequency (BCF), and percentage of linearity (LIN, VSL/VCL × 100%). For each experimental condition, five random fields were evaluated for a minimum total of 100 cells in each field.
Full text: Click here
Publication 2023
4-nitrophenylphosphorylcholine 8-bromocyclic GMP Cells Chaperone-Mediated Autophagy Diltiazem Head Sperm Sperm Motility Training Programs

Top products related to «Diltiazem»

Sourced in United States, Germany, Belgium, France
Diltiazem is a laboratory equipment product manufactured by Merck Group. It is a calcium channel blocker used in scientific research and analysis.
Sourced in United States, Germany, United Kingdom, China, Sao Tome and Principe, France, Italy, Australia, Canada, Israel, Belgium, Sweden, Brazil, Spain, India
Nifedipine is a pharmaceutical compound used in the production of lab equipment. It is a calcium channel blocker that can be used to regulate the flow of calcium into cells. The core function of Nifedipine is to control and maintain the balance of calcium levels within a controlled environment.
Sourced in United States, Germany, France, United Kingdom, China, Japan, Spain, Italy, Sao Tome and Principe, Switzerland, Australia, Ireland, Belgium
Verapamil is a laboratory product manufactured by Merck Group. It is a calcium channel blocker that inhibits the movement of calcium ions through cell membranes, which can affect various physiological processes. The core function of Verapamil is to serve as a research tool for the study of calcium-dependent mechanisms in biological systems.
Sourced in United States, United Kingdom, Italy, Germany, Switzerland
Papaverine is a laboratory chemical compound used as a smooth muscle relaxant. It is often utilized in various in vitro and ex vivo research applications.
Sourced in United States, Germany, United Kingdom, Italy, Sao Tome and Principe, Spain, France, China, Switzerland, Macao
Acetylcholine is a chemical compound that functions as a neurotransmitter in the body. It plays a crucial role in the transmission of signals between nerve cells and muscle cells, as well as within the central nervous system.
Sourced in United States, United Kingdom, Germany, Italy, France, Spain, Australia, Japan, China, Canada, Belgium, Austria, Hungary, Macao
Fura-2 AM is a fluorescent calcium indicator used for measuring intracellular calcium levels. It is a cell-permeable derivative of the parent compound Fura-2. Fura-2 AM can be loaded into cells, where intracellular esterases cleave off the acetoxymethyl (AM) ester group, trapping the Fura-2 indicator inside the cell.
Sourced in United States, Germany, United Kingdom, Sao Tome and Principe, France, Brazil, Italy, Belgium, China, Canada, Spain
L-NAME is a synthetic compound that functions as a nitric oxide synthase inhibitor. It is commonly used in research applications to study the role of nitric oxide in biological processes.
Sourced in United Kingdom
Diltiazem is a laboratory reagent used for various research applications. It is a calcium channel blocker that can be used to study the effects of calcium regulation on cellular processes. The core function of Diltiazem is to modulate calcium-dependent signaling pathways in biological systems.
Sourced in United States
Diltiazem is a pharmaceutical product used in various laboratory applications. It is a calcium channel blocker that affects the movement of calcium into the cells of the heart and blood vessels. The core function of Diltiazem is to regulate and control the flow of calcium in these cells, which can have an impact on various physiological processes. This product may be utilized in a range of laboratory experiments and research procedures, but a detailed description of its intended use cannot be provided in an unbiased and factual manner without potential for extrapolation.
Sourced in United States
L-Cis diltiazem is a chemical compound used in research laboratories. It is a calcium channel blocker that inhibits the movement of calcium ions across cell membranes.

More about "Diltiazem"

Diltiazem, a calcium channel blocker medication, is commonly used to manage a variety of cardiovascular conditions, including hypertension, angina pectoris, and certain heart rhythm disorders.
This drug works by relaxing blood vessels and reducing the workload on the heart, leading to improved blood flow and reduced strain on the cardiovascular system.
Diltiazem is often prescribed alongside other medications like Nifedipine, Verapamil, and Papaverine, which are also calcium channel blockers with similar mechanisms of action.
These drugs can be used in combination to optimize the management of complex cardiovascular issues.
In addition to its primary therapeutic uses, Diltiazem has been studied for its effects on other physiological processes, such as the modulation of acetylcholine-mediated responses and the regulation of intracellular calcium levels, as demonstrated by the use of Fura-2 AM as a calcium indicator.
Proper dosing and careful consideration of potential interactions are crucial when prescribing Diltiazem, as evidenced by the use of L-NAME, a nitric oxide synthase inhibitor, which can impact the drug's efficacy.
Additionally, the L-Cis diltiazem stereoisomer has been investigated for its potentially enhanced pharmacological properties compared to the racemic mixture.
Overall, Diltiazem is a versatile and important cardiovascular medication that requires a nuanced understanding of its pharmacology and clinical applications to ensure optimal patient outcomes.